Medical Oncologist

(MD) - Dr. Evan J. Lipson, MD

(MD) - Dr. Evan J. Lipson, MD

Evan J. Lipson, M.D., is a medical oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology at Johns Hopkins University School of Medicine. Dr. Lipson established the Johns Hopkins Melanoma Program at Sibley in 2012 and opened the program's first clinical trial in the Washington, D.C. region in 2015. He is board certified in internal medicine and medical oncology. 

Dr. Lipson has an expertise in melanoma and treatment of patients with cutaneous malignancies, specifically regarding the use of novel immunotherapies. 

(MN) – Dr. Lance C. Pagliaro, MD

(MN) – Dr. Lance C. Pagliaro, MD

Lance C. Pagliaro, M.D., conducts research in kidney, prostate, bladder, testicular and penile cancers. Dr. Pagliaro specializes in the medical treatment of these conditions using immuno-oncology drugs and other targeted therapies.

Dr. Pagliaro is interested in how molecularly targeted drugs and immune checkpoint inhibitors can be combined for the treatment of advanced renal cell carcinoma and prostate cancer. He also studies novel drug combinations for the treatment of metastatic bladder cancer.

(TX) - Dr. Robert G. Mennel, MD

(TX) - Dr. Robert G. Mennel, MD

Robert G. Mennel, M.D. specializes in medical oncology and hematology with board certification in both internal medicine and medical oncology. He is a Diplomate of the American Board of Internal Medicine with subspecialty certification in medical oncology.

Dr. Mennel received an M.D. from the University of Pennsylvania Medical School in 1970. He completed training in internal medicine at the University of Rochester, Strong Memorial Hospital, in 1974, and a fellowship in hematology and oncology at Johns Hopkins Oncology Center in 1979.